Anti-ADGRG4 monoclonal antibody

Pre-made anti-ADGRG4 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ADGRG4/ADGRG4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0928-Ab-1/ GM-Tg-hg-IP0928-Ab-2Anti-Human ADGRG4 monoclonal antibodyHuman
GM-Tg-rg-IP0928-Ab-1/ GM-Tg-rg-IP0928-Ab-2Anti-Rat ADGRG4 monoclonal antibodyRat
GM-Tg-mg-IP0928-Ab-1/ GM-Tg-mg-IP0928-Ab-2Anti-Mouse ADGRG4 monoclonal antibodyMouse
GM-Tg-cynog-IP0928-Ab-1/ GM-Tg-cynog-IP0928-Ab-2Anti-Cynomolgus/ Rhesus macaque ADGRG4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0928-Ab-1/ GM-Tg-felg-IP0928-Ab-2Anti-Feline ADGRG4 monoclonal antibodyFeline
GM-Tg-cang-IP0928-Ab-1/ GM-Tg-cang-IP0928-Ab-2Anti-Canine ADGRG4 monoclonal antibodyCanine
GM-Tg-bovg-IP0928-Ab-1/ GM-Tg-bovg-IP0928-Ab-2Anti-Bovine ADGRG4 monoclonal antibodyBovine
GM-Tg-equg-IP0928-Ab-1/ GM-Tg-equg-IP0928-Ab-2Anti-Equine ADGRG4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0928-Ab-1/ GM-Tg-hg-IP0928-Ab-2; GM-Tg-rg-IP0928-Ab-1/ GM-Tg-rg-IP0928-Ab-2;
GM-Tg-mg-IP0928-Ab-1/ GM-Tg-mg-IP0928-Ab-2; GM-Tg-cynog-IP0928-Ab-1/ GM-Tg-cynog-IP0928-Ab-2;
GM-Tg-felg-IP0928-Ab-1/ GM-Tg-felg-IP0928-Ab-2; GM-Tg-cang-IP0928-Ab-1/ GM-Tg-cang-IP0928-Ab-2;
GM-Tg-bovg-IP0928-Ab-1/ GM-Tg-bovg-IP0928-Ab-2; GM-Tg-equg-IP0928-Ab-1/ GM-Tg-equg-IP0928-Ab-2
Products NameAnti-ADGRG4 monoclonal antibody
Formatmab
Target NameADGRG4
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ADGRG4 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0928-Ag-1Recombinant multi-species AGRG4/ ADGRG4/ GPR112 protein


    Target information

    Target IDGM-IP0928
    Target NameADGRG4
    Gene ID139378,236798,302860,100424734,492163,111558686,100056865
    Gene Symbol and SynonymsADGRG4,Gm367,GPR112,Gpr112l,PGR17,RGD1564057,RP1-299I16
    Uniprot AccessionQ8IZF6
    Uniprot Entry NameAGRG4_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000156920
    Target ClassificationGPCR

    The target: ADGRG4, gene name: ADGRG4, also named as GPR112, PGR17, RP1-299I16. This gene encodes a G-protein coupled receptor belonging to a large family of diverse integral membrane proteins that participate in various physiological functions. Members of this superfamily are characterized by a signature 7-transmembrane domain motif. The ligand for this family member is unknown, and it is therefore an orphan receptor. This receptor is known to be expressed in normal enterochromaffin cells and in gastrointestinal neuroendocrine carcinoma cells, and it is therefore considered to be a novel biomarker or target for immunotherapy. [provided by RefSeq, May 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.